Phase 1 study of radiosensitization using bortezomib in patients with relapsed non-Hodgkin lymphoma receiving radioimmunotherapy with 131I-tositumomab.
Elstrom RL, Ruan J, Christos PJ, Martin P, Lebovic D, Osborne J, Goldsmith S, Greenberg J, Furman RR, Avram A, Putman R, Chapman E, Mazumdar M, Griffith K, Coleman M, Leonard JP, Kaminski MS.
Elstrom RL, et al.
Leuk Lymphoma. 2015 Feb;56(2):342-6. doi: 10.3109/10428194.2014.914195. Epub 2014 Jun 17.
Leuk Lymphoma. 2015.
PMID: 24730538
Free PMC article.
Clinical Trial.